Empirical Antibiotic Treatment for Septic Shock
Initial Antibiotic Selection
- The Society of Critical Care Medicine recommends that intravenous antimicrobials must be initiated as soon as possible and within one hour of recognizing septic shock to reduce mortality 1, 2
- Empiric broad-spectrum therapy should cover all likely pathogens (bacterial, potentially fungal or viral) 1, 2
- For septic shock, use combination therapy with at least two antibiotics from different antimicrobial classes 1, 2
- For respiratory failure with septic shock: combine an extended-spectrum β-lactam with either an aminoglycoside or fluoroquinolone when Pseudomonas aeruginosa is suspected 1, 2
- For septic shock from Streptococcus pneumoniae bacteremia: combine a β-lactam with a macrolide 1, 2
Duration and De-escalation
- Empiric combination therapy should not be administered for more than 3-5 days 1, 2
- De-escalation to the most appropriate single therapy should be performed once susceptibility profile is known 1, 2
- Daily assessment for de-escalation of antimicrobial therapy is recommended 1, 2
- Standard duration for serious infections associated with sepsis and septic shock is 7-10 days 1, 2
Special Considerations for Extended Treatment
- Longer courses may be appropriate in patients with slow clinical response to initial therapy 1, 2
- Longer courses may be appropriate in patients with undrainable foci of infection 1, 2
- Longer courses may be appropriate in patients with bacteremia with Staphylococcus aureus 1, 2
- Longer courses may be appropriate in patients with fungal and viral infections 1, 2
- Longer courses may be appropriate in patients with immunologic deficiencies, including neutropenia 1, 2
Dosing Optimization
Common Pitfalls to Avoid
- Failure to de-escalate: Continuing broad-spectrum antibiotics beyond 3-5 days when culture results are available increases resistance risk 1, 2
- Inappropriate duration: Treating longer than necessary (typically >10 days) without specific indications 1, 2
- Antimicrobial agents should not be used in patients with severe inflammatory states determined to be of noninfectious cause 1, 2